Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.

ABSTRACT:

SUBMITTER: Sandmaier BM 

PROVIDER: S-EPMC6686903 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature